AMAVATA: AYURVEDIC PATHOGENESIS, CLINICAL CORRELATION WITH RHEUMATOID ARTHRITIS, AND EVIDENCE-BASED MANAGEMENT

Abstract

Amavata is a classical Ayurvedic disorder characterized by the association of Ama with
aggravated Vata, followed by systemic circulation, Srotorodha and localization in Sandhi.
Clinically, it is described with Sandhi Shoola (joint pain), Sandhi Graha or Stambha (restricted
movement and stiffness), Sandhi Shotha (swelling), Angamarda, Gaurava, Aruchi and other
constitutional features. Because this pattern overlaps with inflammatory polyarthritis, Amavata is
frequently discussed in relation to rheumatoid arthritis (RA), although the two arise from
different diagnostic and explanatory systems and should not be considered completely identical.
(Madhavakara, 2012)
Rheumatoid arthritis is a chronic systemic autoimmune inflammatory disease characterized
by persistent synovitis, autoantibody formation and progressive cartilage and bone damage.
Contemporary evidence links RA to genetic susceptibility, environmental and mucosal exposures,
loss of immune tolerance and cytokine-driven synovial inflammation. This biomedical
framework provides measurable outcomes joint counts, inflammatory markers, serology, imaging
and disease-activity scores—that can be used alongside, but not substituted for, classical
Ayurvedic assessment of Ama, Agni, Dosha, Srotas and disease stage. (Smolen et al., 2023)
This review synthesizes the supplied Amavata material with classical Ayurvedic principles
and peer-reviewed evidence on rheumatoid arthritis, emphasizing Nidana, Samprapti, clinical
manifestations, Sandhi Shoola, Sandhi Graha, Ayurvedic treatment, Rasayana and modern
disease monitoring. Available clinical studies suggest potential improvements in pain, stiffness,
function and inflammatory indices with selected Ayurvedic interventions, but limitations include
small samples, heterogeneous formulations, incomplete blinding and inconsistent safety
reporting. Ayurvedic approaches are therefore best investigated as structured, quality-controlled
and clinically monitored interventions, particularly as adjuncts to established disease-modifying
care in active RA. (Chawla et al., 2026)